Perivascular sustained release of atorvastatin from a hydrogel-microparticle delivery system decreases intimal hyperplasia

A combination of a sustained (from microparticles) and fast (from hydrogel) release of atorvastatin is necessary to inhibit intimal hyperplasia. The formulation is placed perivascularly, and atorvastatin permeates the vascular wall.171